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New hexacyclo and octacyclo compounds have been synthesized by a short route whose key step 36 
consists of a single or double domino nucleophilic substitution of neopentyl-type iodides with potassium 37 




Polycyclic and cage compounds are of current interest in medicinal chemistry.[1–4] In connection with 42 
this potential application, we recently described the synthesis of a 2,8-ethanonoradamantane 43 
derivative.[5] Diamondoid derivatives[6] are of interest in connection with host-guest molecular 44 
recognition, materials chemistry, molecular machines and rotors, etc. Polytwistanes[7,8] are being 45 
studied as chiral hydrocarbon nanotubes, and polynorbornane derivatives[9] have been used to prepare 46 
coordination cages (Figure 1). In this paper, a short route to functionalized bridged di- and tri-47 
norbornane derivatives is described. These compounds might be used, among other applications, as new 48 
scaffolds for the preparation of biologically active compounds, or as building blocks for the synthesis of 49 
new polynorbornanebased ligands. 50 
 51 
52 
RESULTS AND DISCUSSION 53 
 54 
An important feature of these syntheses was the preparation of cyclopenta-2,4-diene-1,1-55 
diylbis(methylene) diacetate (6) according to Scheme 1. Dimethyl bisallylmalonate (1)[10,11] was 56 
transformed into dimethyl cyclopent-3-ene-1,1-dicarboxylate (2) by reaction with Grubbs first 57 
generation catalyst. Compound 2 was alternatively prepared by reaction of dimethyl malonate with cis-58 
1,4-dichloro-2-butene.[12] Reduction of diester 2 followed by acetylation gave known diacetate 4. 59 
Reaction of 4 with N-bromosuccinimide (NBS)  in the presence of 2,2 -azo-bis(isobutyronitrile) 60 
(AIBN) as described in a related case,[13] gave allylic bromide 5, which, on reaction with quinoline at 61 
high temperature,[14] gave the desired diacetate (i.e., 6). 62 
Reaction of cyclopentadiene 6 with dimethyl acetylenedicarboxylate (1.5 equiv.) gave the corresponding 63 
Diels–Alder adduct 7 in good yield (Scheme 2). Methanolysis of the acetate groups of this compound 64 
with K2CO3 in MeOH gave a stereoisomeric mixture of alcohols 8 and 9 in a ratio 8/9 of about 9:1 [on 65 
the basis of integration of the singlet signals of one of the COOMe groups of 8 (δ = 3.70 ppm) and 9 (δ 66 
= 3.57 ppm) in the 1H NMR spectrum of the mixture]. These compounds are reasonably formed by 67 
Michael addition of the syn alcohol functionality of the intermediate diol onto the butenedioate 68 
substructure. Compound 8 was isolated as a racemate from its mixture with 9 by crystallization from 69 
EtOAc, and was fully characterized spectroscopically. The exo stereochemistry of the ester functionality 70 
at C-7 was clearly assigned on the basis of its 1H NMR spectrum, in which the 7-H proton appears as a 71 
singlet as the value of its coupling constant with 4-H is close to zero (dihedral angle H–C-7–C-4–H 72 
close to 90°). The stereochemistry of 8 was also secured by X-ray diffraction analysis. Figure 2 shows 73 
the ORTEP representation of one of the enantiomers. The synthetic sequence was continued with 74 
racemic alcohol 8. Mesylation of 8 by a standard procedure gave mesylate 10, which was transformed 75 
into iodide 11 by reaction with NaI in acetone. Both transformations took place in good yield. 76 
Treatment of this iodide with potassium cyclopentadienide in DMF in the presence of 18-crown-6 (5 77 
mol-%)[15,16] gave polycycle 12, as a result of nucleophilic substitution of the neopentyl-type iodide 78 
by the cyclopentadienide anion, followed by intramolecular Diels–Alder reaction, in good yield. 79 
Although polycycle 12 was fully characterized spectroscopically, and by elemental analysis and accurate 80 
mass measurement, its structure was secured by X-ray diffraction analysis. Figure 3 shows the ORTEP 81 
representation of one of the enantiomers of 12. 82 
Acid-catalyzed methanolysis of diacetate 7 gave a mixture of diol 13 plus alcohols 8 and 9 in a ratio 83 
about 20:12:5 (by 1H NMR spectroscopy; Scheme 3). From this mixture, diol 13 could not be isolated in 84 
pure form since partial conversion into alcohols 8 and 9 took place during attempted purification by 85 
silica gel column chromatography. Consequently, the above mixture was transformed into a mixture of 86 
dimesylate 14 and monomesylate 10 and its C-7 epimer. Upon treatment with NaI in acetone, this 87 
mixture gave a mixture of diiodide 15 and monoiodide 11 and its C-7 epimer. This mixture was 88 
separated by silica gel column chromatography into two fractions: diiodide 15 (31% overall yield from 89 
diacetate 7), and a mixture of monoiodide 11 and its C-7 epimer (28% overall yield from 7). 90 
Reaction of diiodide 15 with potassium cyclopentadienide as before gave polycycle 26 in 49% yield. 91 
The formation of this compound implies a double nucleophilic substitution of the neopentyl-type iodides 92 
by the cyclopentadienide anion, followed by a double intramolecular Diels–Alder reaction. Compound 93 
16 was fully characterized analytically and spectroscopically, including X-ray diffraction analysis. 94 
Figure 4 shows the ORTEP representation of polycycle 16. 95 
To the best of our knowledge, although these domino processes appear conventional, the only related 96 
transformation described to date[17] is the reaction of a stereoisomeric mixture of dimethyl 7-97 
(dimethoxymethyl)norborna-2,5-diene-2,3-dicarboxylate with trimethylsilylcyclopentadiene catalyzed 98 





In conclusion, a short route to complex functionalized polycycles that could be of interest as new 104 
scaffolds for the preparation of biologically active compounds and coordination cages has been 105 
developed. The key points of the synthesis are: (i) a convenient preparation of 1,1-disubstituted 106 
cyclopentadiene 6, and (ii) a single or double domino nucleophilic substitution of neopentyl-type iodides 107 
by cyclopentadienide anion/Diels–Alder reaction that introduces three or six new rings into the 108 
corresponding products, i.e., 11 or 15 respectively, in a one-pot transformation. 109 
110 
EXPERIMENTAL SECTION 111 
 112 
General Methods: Melting points were determined in open capillary tubes with an MFB 595010M 113 
Gallenkamp melting-point apparatus. 1H and 13C NMR spectra were recorded with a Varian Mercury 114 
400 (400 MHz for 1H; 100.6 MHz for 13C) spectrometer in CDCl3. Chemical shifts (δ) are reported in 115 
parts per million relative to tetramethylsilane, and spectra were calibrated using internal 116 
tetramethylsilane or residual CHCl3/CDCl3. Multiplicities are reported using the following 117 
abbreviations: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad, or their combinations. Assignments 118 
given for the NMR spectra are based on DEPT, COSY, NOESY, 1H/13C single quantum correlation 119 
(gHSQC sequence), and 1H/13C multiple bond correlation (gHMBC sequence) spectra. IR spectra were 120 
recorded with an FTIR Perkin–Elmer Spectrum RX1 spectrometer using the attenuated total reflectance 121 
(ATR) technique. Absorption values are given as wavenumbers (cm–1), and the intensity of the 122 
absorptions are given as strong (s), medium (m), or weak (w). High-resolution mass spectra (HRMS) 123 
were carried out at the mass spectrometry unit of the Centres Científics i Tecnològics de la Universitat 124 
de Barcelona (CCiTUB) with an LC/MSD-TOF spectrometer with electrospray ionization (ESI-TOF-125 
MS) from Agilent Technologies. Elemental analyses were carried out at the IIQAB (CSIC) of 126 
Barcelona, Spain, with elemental microanalyzers (A5) model Flash 1112 series and (A7) model Flash 127 
2000 series from Thermofinnigan for (C, H, N) and (C, H, N, S) determinations, respectively. Silica gel 128 
60 AC (35–70 mm, SDS, ref. 2000027) was used for flash column chromatography. The eluents used 129 
are reported as volume/volume percentages. Thin-layer chromatography (TLC) was carried out on 130 
aluminum-backed sheets with silica gel 60, 254 nm indicator (Fluka–Sigma–Aldrich), and spots were 131 
visualized with UV light or a solution of KMnO4 (1% aq.). X-ray diffraction analysis was carried out 132 
with a D8 Venture diffractometer at the CCiTUB of the University of Barcelona. Allyl bromide, NBS, 133 
18-crown-6, 4-(dimethylamino)pyridine, dimethyl acetylenedicarboxylate, dimethyl malonate, Grubbs 134 
first generation catalyst, KH (30 %), LiAlH4, and p-toluenesulfonic acid were obtained from Sigma–135 
Aldrich; AIBN, dicyclopentadiene, and quinoline were obtained from Fluka; all of these reagents were 136 
used without further purification. 137 
 138 
(4-Bromocyclopent-2-ene-1,1-diyl)bis(methylene) Diacetate (5): NBS (856 mg, 4.81 mmol) and 139 
AIBN (79 mg, 0.48 mmol, 10 mol-%) were added to a magnetically stirred solution of diacetate 4 (1.02 140 
g, 4.81 mmol) in CCl4 (14.6 mL) under an Ar atmosphere. The resulting orange-colored stirred 141 
suspension was heated at 65 °C for 15 min, and then at 90 °C for 1 h. The grey suspension was then 142 
cooled with an ice/water bath; the solid precipitate was removed by filtration, and washed with cold 143 
 CH2Cl2 (3  5 mL). The combined filtrate and washings were washed with saturated aqueous NaHCO3 144 
 (3  10 mL) and brine (10 mL), dried (anhydrous Na2SO4), and concentrated in vacuo to give crude 145 
bromide 5 (1.31 g, 94%) as a yellow oil, which was used as such in the next step. Rf (hexane/EtOAc, 146 
1:1): 0.42. IR (ATR): ν˜ = 3067 (w), 2952 (m), 2893 (w), 1736 (s), 1466 (m), 1437 (m), 1379 (s), 1364 147 
(s), 1232 (s), 1183 (m), 1043 (s), 981 (m), 906 (m), 809 (m), 786 (m), 765 (m) cm–1. HRMS: calcd. for 148 
[C11H15 79BrO4 + H]+ 291.0226; found 292.0219. 1H NMR: δ = 2.05 (s, 3 H) and 2.09 (s, 3 H) (2 149 
 CH3COO), 2.35 (dd, J = 15.6, J  = 2.4 Hz, 1 H, 5-Ha), 2.47 (dd, J  = 15.6, J  = 7.6 Hz, 1 H, 5-Hb), 150 
3.95 (d, J = 11.0 Hz, 1 H) and 4.10 (d, J = 11.0 Hz, 1 H) (CH2OAc), 4.20 (s, 2 H, CH2OAc), 5.05–5.08 151 
     (ddt, J = 7.6, J  = 2.4, J  = 0.8 Hz, 1 H, 4-H), 5.80 (d, J = 5.6 Hz, 1 H, 2-  H), 6.08 (dd, J = 5.4, J  = 152 
2.2 Hz, 1 H, 3-H) ppm. 13C NMR: δ = 20.75 (CH3) and 20.85 (CH3) (2 OCOCH3), 41.0 (CH2, C-5), 153 
52.7 (CH, C-4), 53.5 (C, C-1), 65.6 (CH2) and 66.7 (CH2, 2 CH2OAc), 135.7 (CH) and 136.0 (CH, C-2 154 
and C-3), 170.7 (C) and 170.8 (C, 2 CH3COO) ppm.  155 
 156 
 157 
Cyclopenta-2,4-diene-1,1-diylbis(methylene) Diacetate (6): A magnetically stirred solution of bromo 158 
diacetate 5 (3.79 g, 13.0 mmol) in anhydrous quinoline (6.9 mL, 58.6 mmol) under an Ar atmosphere 159 
was heated at 180 °C for 1 h. The dark mixture was cooled with an ice/water bath, then Et2O (15 mL) 160 
was added. The mixture was stirred for 5 min, and then it was washed with HCl (2 n aq.;  4  10 mL) and 161 
water (20 mL). The brown organic phase was dried (anhydrous Na2SO4), and concentrated in vacuo to 162 
give diene 6 (2.38 g, 88%) as a brown oil, which was used as such in the next step. An analytical sample 163 
of 6 was obtained by column chromatography of a sample of the above product (205 mg) [35–70 μm 164 
silica gel (6.1 g), pentane/EtOAc mixtures]. On elution with pentane/EtOAc, 96:4, diene 6 (165 mg) was 165 
isolated as a pale yellow oil that solidified on standing. m.p. 42–43 °C. Rf (silica gel, 10 cm, 166 
hexane/EtOAc, 1:1): 0.56. IR (ATR): ν˜ = 3076 (w), 2978 (m), 2959 (m), 2897 (m), 2850 (w), 1736 (s), 167 
1466 (m), 1430 (m), 1376 (s), 1227 (s), 1078 (m), 1032 (s), 978 (s), 922 (m), 896 (m), 753 (s) cm–1. 168 
C11H14O4 (210.23): calcd. C 62.85, H 6.71; found C 62.97, H 6.90. HRMS: calcd. for [C11H14O4 + 169 
NH4]+ 228.1230; found 228.1233; calcd. for [C11H14O4 + H]+ 211.0965; found 211.0965. 1H NMR: 170 
δ = 2.08 (s, 6 H, 2 CH3COO), 4.07 (s, 4 H, 2 CH2OAc), 6.33–6.35 [m, 2 H, 2(5)-H], 6.47–6.48 [m, 2 H, 171 
3(4)-H] ppm. 13C NMR: δ = 20.9 (CH3, 2 OCOCH3), 59.5 (C, C-1), 63.6 (CH2, 2 CH2OAc), 133.6 172 
[CH, C-2(5)], 137.4 [CH, C-3(4)], 170.7 (C, 2 CH3COO) ppm. 173 
 174 
Dimethyl 7,7-Bis(acetoxymethyl)bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (7): A solution of 175 
crude diene 6 (624 mg, 2.97 mmol) and dimethyl acetylenedicarboxylate (0.55 mL, 633 mg, 4.45 mmol) 176 
in toluene (5 mL) was heated at 80 °C for 72 h. The solution was then cooled to room temperature, and 177 
the solvent was removed in vacuo. The brown oily residue was subjected to column chromatography 178 
[35–70 μm silica gel (25 g), hexane/EtOAc mixtures]. On elution with hexane/EtOAc, 3:1, adduct 7 179 
(820 mg, 78%) was isolated as a pale yellow oil. Rf (silica gel, 10 cm, hexane/EtOAc, 3:7): 0.47. IR 180 
(ATR): ν˜ = 3000 (w), 2955 (w), 1731 (s), 1713 (s), 1630 (m), 1435 (m), 1376 (m), 1366 (m), 1317 (m), 181 
1218 (s), 1099 (m), 1031 (s), 734 (m) cm–1. C17H20O8 (352.34): C 57.95, H 5.72%; found C 57.98, H 182 
5.89%. HRMS: calcd. for [C17H20O8 + H]+ 353.1231; found 353.1239. 1H NMR: δ = 2.028 (s, 3 H) 183 
and 2.031 (s, 3 H, 2 CH3COO), 3.74 [pseudo t, J = 2.0 Hz, 2 H, 1(4)-H], 3.79 [s, 6 H, C-2(3)-COOMe], 184 
4.25 (s, 2 H, syn-CH2OAc) and 4.29 (s, 2 H, anti CH2OAc), 6.87 [pseudo t, J = 2.2 Hz, 2 H, 5(6)-H] 185 
ppm. NOESY: irradiation at δ = 6.87 ppm shows an NOE with the protons appearing at δ = 3.74 [1(4)-186 
H] and 4.25 (syn-CH2OAc) ppm. 13C NMR: δ = 20.7 (CH3, CH3COO), 20.8 (CH3, CH3COO), 52.2 187 
(CH3, 2 COOCH3), 56.7 [CH, C-1(4)], 63.7 (CH2, CH2OAc), 63.8 (CH2, CH2OAc), 85.7 (C, C-7), 188 
140.9 [CH, C-5(6)], 150.2 [C, C-2(3)], 164.7 [C, C-2(3)-COOMe], 170.50 (C, anti-CH3COO), 170.54 189 
(C, syn-CH3COO) ppm. Dimethyl (1RS,3aRS,4SR,6aSR,7SR)-3a-(Hydroxymethyl)-3,3a,4,6a-190 
tetrahydro-1H-1,4-methanocyclopenta[c]furan-1,7-dicarboxylate (8): Anhydrous K2CO3 (40 mg, 0.29 191 
mmol) was added to a solution of diacetate 7 (413 mg, 1.17 mmol) in anhydrous MeOH (2.5 mL), and 192 
the mixture was stirred at 30 °C for 2 h. The mixture was cooled to 0 °C (ice/water bath), and filtered. 193 
The solid was  washed with MeOH (4  5 mL). The combined filtrate and washings were concentrated in 194 
vacuo to give a brown solid (369 mg), containing a stereoisomeric mixture of 8 and its C-7 epimer 9, in 195 
a ratio 8/9 = 9:1 (by 1H NMR spectroscopy). This mixture was subjected to column chromatography 196 
[35–70 μm silica gel (11 g), hexane/EtOAc mixtures]. On elution with hexane/EtOAc, 3:2 to 1:1, a 197 
stereoisomeric mixture of 8 and 9 (168 mg), in a ratio 8/9 = 9:1, was obtained. By heating this solid in 198 
refluxing EtOAc (0.5 mL), an analytical sample of 8 (101 mg, 32%) was obtained as a white solid. m.p. 199 
118–120 °C (EtOAc). Rf (silica gel, 10 cm, hexane/ EtOAc, 3:7): 0.28. IR (ATR): ν˜ = 3488 (m), 3426 200 
(m), 2954 (w), 2903 (w), 2871 (w), 1721 (s), 1439 (m), 1325 (s), 1217 (s), 1196 (s), 1170 (s), 1156 (s), 201 
1064 (s), 1037 (s), 1016 (s), 1000 (m), 926 (m), 888 (m), 730 (s), 658 (m) cm–1. C13H16O6 (268.26): C 202 
58.20, H 6.01; found C 58.20, H 6.14. HRMS: calcd. for [C13H16O6 +Na]+ 291.0839; found 291.0841. 203 
1H NMR: δ = 1.59 (s, 1 H, OH), 2.74 (s, 1 H, 7-H), 3.07–3.09 (m, 1 H, 6a-H), 3.19–3.21 (m, 1 H, 4-H), 204 
3.62 (br. d, J = 9.0 Hz, 1 H) and 3.68 (br. d, J = 9.0 Hz, 1 H, CH2OH), 3.70 (s, 3 H, C-1-COOCH3), 205 
3.81 (s, 3 H, C-7- COOCH3), 3.96 (d, J = 8.8 Hz, 1 H) and 4.00 (d, J = 8.8 Hz, 1 H, 3-Ha and 3-Hb), 206 
5.93–      5.95 (ddd, J = 5.8, J  = 3.0, J  = 1.0 Hz, 1 H, 6-H), 6.39–  6.42 (dd, J = 5.8, J  = 3.0 Hz, 1 H, 5-207 
H) ppm. 13C NMR: δ = 48.0 (CH, C-4), 52.2 (CH3, C-1-COOCH3), 52.6 (CH3, C-7-COOCH3), 56.9 208 
(CH, C-7), 59.1 (CH, C-6a), 59.6 (CH2, CH2OH), 68.6 (CH2, C-3), 75.4 (C, C-3a), 85.7 (C, C-1), 128.0 209 
(CH, C-6), 139.8 (CH, C-5), 170.9 (C, C-7-COOMe), 171.1 (C, C-1-COOMe) ppm. NMR spectroscopic 210 
data of 9: A mixture of 8 and 9 (120 mg) in a ratio of ca. 1.5:10 was obtained by silica gel column 211 
chromatography as part of an operation to prepare diol 13 (see below). The NMR spectroscopic data for 212 
9 are given based on this mixture. 1H NMR: δ = 1.53 (br. s, 1 H, OH), 3.02–3.04 (m, 1 H, 6a-H), 3.12–213 
3.15 (m, 1 H, 4-H), 3.34 (d, J = 4.4 Hz, 1 H, 7-H), 3.57 (s, 3 H, C-1-COOMe), 3.61 (br. d, J = 11.2 Hz, 1 214 
H) and 3.69 (br. d, J = 11.2 Hz, 1 H, CH2OH), 3.77 (s, 3 H, C-7-COOMe), 3.82 (d, J = 9.0 Hz, 1 H) and 215 
3.98 (d, J = 9.0 Hz, 1 H, 3-Ha and 3-Hb), 6.10      (ddd, J = 5.6, J  = 3.2, J  = 0.8 Hz, 1 H, 6-H), 6.16 216 
(dd, J = 5.6,  J  = 2.8 Hz, 1 H, 5-H) ppm. 13C NMR: δ = 49.0 (CH, C-4), 51.7 (CH3, C-1-COOCH3), 217 
52.3 (CH3, C-7-COOCH3), 55.8 (CH, C-6a), 55.9 (CH, C-7), 59.4 (CH2, CH2OH), 68.2 (CH2, C-3), 218 
73.1 (C, C- 3a), 88.8 (C, C-1), 129.6 (CH, C-6), 135.7 (CH, C-5), 169.3 (C, C-7-COOMe), 169.7 (C, C-219 
1-COOMe) ppm. Dimethyl (1RS,3aRS,4SR,6aSR,7SR)-3a-{[(Methylsulfonyl)-oxy]methyl}-3,3a,4,6a-220 
tetrahydro-1H-1,4-methanocyclopenta[c]-furan-1,7-dicarboxylate (10): Methanesulfonyl chloride (0.03 221 
mL, 0.36 mmol) was added dropwise to a cold (0 °C, ice/water bath) and magnetically stirred solution of 222 
alcohol 8 (80 mg, 0.3 mmol) and anhydrous Et3N (0.1 mL, 0.69 mmol) in CH2Cl2 (3.3 mL) under an 223 
Ar atmosphere. The mixture was stirred at this temperature for 2 h. Saturated aqueous NaHCO3 (1 mL) 224 
was then added. The organic phase was separated, and was washed with saturated aqueous NaHCO3 225 
 (3  3 mL). The combined aqueous phases were extracted with CH  2Cl2 (3  5 mL). The combined 226 
organic phase and extracts were washed with water (3 mL) and brine (3 mL), dried (anhydrous 227 
Na2SO4), and concentrated in vacuo to give a solid residue (101 mg) that was subjected to column 228 
chromatography [35–70 μm silica gel (1.0 g), hexane/EtOAc]. On elution with hexane/EtOAc, 7:3, 229 
mesylate 10 (87 mg, 85%) was obtained as a white solid. m.p. 144–145 °C (hexane/EtOAc). Rf (silica 230 
gel, 10 cm, hexane/EtOAc, 1:4): 0.45. IR (ATR): ν˜ = 2960 (w), 2923 (w), 2901 (w), 2850 (w), 1731 (s), 231 
1462 (w), 1439 (m), 1346 (s), 1338 (s), 1329 (s), 1224 (s), 1084 (s), 1172 (s), 1161 (s), 1066 (s), 956 (s), 232 
938 (s), 854 (s), 836 (s), 742 (s), 729 (s) cm–1. C14H18O8S (346.35): C 48.55, H 5.24, S 9.26%; found 233 
C 48.64, H 5.42, S 9.07%. HRMS: calcd. for [C14H18NO8S + H]+ 347.0795; found 347.0793; calcd. 234 
For [C14H18NO8S + NH4]+ 364.1061; found 364.1060. 1H NMR: δ = 2.79 (s, 1 H, 7-H), 2.99 (s, 3 H, 235 
CH3SO3), 3.14–3.16 (m, 1 H, 6a-H), 3.29–3.31 (m, 1 H, 4-H), 3.72 (s, 3 H, C-1-COOCH3), 3.83 (s, 3 236 
H, C-7-COOCH3), 3.94 (d, J = 8.8 Hz, 1 H) and 4.01 (d, J = 8.8 Hz, 1 H, 3-Ha and 3-Hb), 4.23 (d, J = 237 
10.4 Hz, 1 H) and 4.30 (d, J = 10.4 Hz, 1 H, CH2OMs), 5.99–  6.02 (ddd, J = 5.8, J  = 3.0,    J  = 0.8 238 
Hz, 1 H, 6-H), 6.44–  6.46 (dd, J = 5.8, J  = 3.0 Hz, 1 H, 5-H) ppm. 13C NMR: δ = 37.5 (CH3, 239 
CH3SO3), 48.3 (CH, C-4), 52.4 (CH3, C-1-COOCH3), 52.8 (CH3, C-7-COOCH3), 56.6 (CH, C-7), 240 
59.3 (CH, C-6a), 66.2 (CH2, CH2OMs), 67.9 (CH2, C-3), 72.7 (C, C-3a), 85.4 (C, C-1), 128.4 (CH, C-241 
6), 139.5 (CH, C-5), 170.1 (C, C-7-COOCH3), 170.6 (C, C-1-COOCH3) ppm. 242 
 243 
Dimethyl (1RS,3aRS,4SR,6aSR,7SR)-3a-(Iodomethyl)-3,3a,4,6atetrahydro-1H-1,4-244 
methanocyclopenta[c]furan-1,7-dicarboxylate (11): Powdered NaI (347 mg, 2.3 mmol) was added to 245 
a solution of mesylate 10 (80 mg, 0.23 mmol) in anhydrous acetone (2.9 mL), and the mixture was 246 
heated at reflux under Ar for 18 h. The mixture was cooled to room temperature, and concentrated in 247 
vacuo. The solid residue was subjected to column chromatography [35–70 μm silica gel (1.0 g), 248 
hexane/EtOAc mixtures]. On elution with hexane/EtOAc, 96:4, iodide 11 (78 mg, 90%) was isolated as 249 
a pale yellow oil. Rf (silica gel, 10 cm, hexane/EtOAc, 3:7): 0.54. IR (ATR): ν˜ = 2949 (w), 2889 (w), 250 
2843 (w), 1731 (s), 1435 (m), 1326 (m), 1257 (m), 1217 (s), 1189 (s), 1164 (s), 1102 (m), 1069 (s), 1000 251 
(m), 728 (s) cm–1. C13H15IO5 (378.16): C 41.29, H 4.00; I 33.56 %; found C 41.43, H 4.14; I 33.30%. 252 
HRMS: calcd. for [C13H15IO5 + H]+ 379.0037; found 379.0033; calcd. for [C13H15IO5 + 253 
Na]+400.9856; found 400.9856. 1H NMR: δ = 2.73 (s, 1 H, 7-H), 3.06–3.09 (br. s, 1 H, 6a-H), 3.23 (d, J 254 
= 10.4 Hz, 1 H) and 3.27 (d, J = 10.4 Hz, 1 H, CHaI and CHbI), 3.32–3.35 (br. s, 1 H, 4-H), 3.71 (s, 3 H, 255 
C-1-COOCH3), 3.81 (s, 3 H, C-7-COOCH3), 3.89 (d, J = 8.8 Hz, 1 H) and 3.98 (d, J = 8.8 Hz, 1 H, 3-256 
Ha and 3-Hb), 5.98–  6.01 (ddd, J = 5.6, J  = 2.8,    J  = 1.2 Hz, 1 H, 6-H), 6.45–6.47  (ddm, J = 5.6, J  257 
= 3.0 Hz, 1 H, 5-H) ppm. 13C NMR: δ = 3.4 (CH2, CH2I), 50.1 (CH, C-4), 52.3 (CH3, C-1-COOCH3), 258 
52.7 (CH3, C-7-COOCH3), 57.2 (CH, C-7), 62.6 (CH, C-6a), 70.9 (CH2, C-3), 73.8 (C, C-3a), 85.5 (C, 259 
C-1), 127.9 (CH, C-6), 139.6 (CH, C-5), 170.5 (C, C-7-COOCH3), 170.6 (C, C-1-COOCH3) ppm. 260 
 261 
Dimethyl (3RS,4SR,4aSR,5SR,5aRS,8SR,8aRS,9aRS, 10SR,11RS)-4a,5,5a,8,8a,9-Hexahydro-1H-262 
3,9a,5,8-(epiethane[1,1,- 2,2]tetrayl)cyclopenta[g]isochromene-3,4(4H)-dicarboxylate (12): In a 10 263 
mL flask, KH (30% in mineral oil; 67 mg, 0.50 mmol) was  washed with anhydrous THF (5  1 mL) 264 
under an Ar atmosphere. Anhydrous THF (1 mL) was added to the washed KH, and the resulting 265 
suspension was cooled to 0 °C in an ice/water bath. Freshly distilled cyclopentadiene (50 μL, 36 mg, 266 
0.54 mmol) was added, and the mixture was stirred at this temperature for 10 min. 18-Crown-6 (7 mg, 267 
26 μmol, ca. 5% relative to KH) was added, and the mixture was stirred at 0 °C for 10 min, and at room 268 
temperature for 15 min to give a pinkish-colored suspension. In a 25 mL flask equipped with a magnetic 269 
stirrer bar and reflux condenser, under an Ar atmosphere, a solution of iodide 11 (50 mg, 0.13 mmol) in 270 
anhydrous DMF (0.8 mL) was prepared. The solution was cooled to 0 °C in an ice/water bath and then, 271 
part of the above solution of potassium cyclopentadienide (0.5 m; 0.27 mL, 0.13 mmol) was added 272 
dropwise. The mixture was stirred at 0 °C for 5 min, and at room temperature for 10 min, and then it 273 
was heated to 90 °C for 17 h. The mixture was cooled to room temperature, MeOH (10 μL) was added, 274 
and the mixture was stirred for 10 min. Then, EtOAc (5 mL) and water (5 mL) were added, and the 275 
organic phase was separated. The aqueous phase was extracted with EtOAc (4   5 mL). The combined 276 
organic phases were washed    with saturated aqueous NaHCO3 (3  5 mL), water (2  5 mL), and brine 277 
(5 mL), dried (anhydrous Na2SO4), and concentrated in vacuo to give crude diester 12 (45 mg) as a 278 
brown oil. This crude product was subjected to column chromatography [35–70 μm silica gel (1.3 g), 279 
hexane/EtOAc mixtures] to give, on elution with hexane/ EtOAc, 94:6, diester 12 (25 mg, 60%) as a 280 
white solid. Crystallization of the above product from CH2Cl2/pentane gave an analytical sample of 12 281 
as a white solid. m.p. 160–161 °C. Rf (silica gel, 10 cm, hexane/EtOAc, 3:7): 0.72. IR (ATR): ν˜ = 2971 282 
(w), 2954 (m), 2928 (m), 2892 (w), 2852 (w), 1755 (s), 1728 (s), 1426 (m), 1349 (m), 1207 (s), 1188 (s), 283 
1164 (s), 1072 (s), 1042 (s), 973 (m), 932 (m), 739 (s), 698 (m) cm–1. C18H20O5·1/3H2O (322.36): C 284 
67.07, H 6.46%; found C 66.79, H 6.23%. HRMS: calcd. for [C18H20O5 + Na]+ 339.1203; found 285 
339.1205. 1H NMR: δ = 1.62 (dd, J = 13.8,  J  = 3.0 Hz, 1 H, 9-Ha), 1.68 (br. d, J = 6.0 Hz, 1 H, 5-H), 286 
1.76 (dd,  J = 14.0, J  = 2.8 Hz, 1 H, 9-Hb), 1.92–1.95 (m, 1 H, 8a-H), 2.03 (br. d, J = 5.6 Hz, 1 H, 11-287 
H), 2.06 (d, J = 1.6 Hz, 1 H, 10- H), 2.42–2.44 (br. s, 2 H, 4a-H and 8-H), 2.49–2.51 (br. s, 1 H, 5a-H), 288 
2.79 (s, 1 H, 4-H), 3.66 (s, 3 H, C-3-COOCH3), 3.70 (d, J = 7.6 Hz, 1 H, 1-Ha), 3.81 (s, 3 H, C-4-289 
COOCH3), 3.92 (dd, J = 7.6,  J  = 0.8 Hz, 1 H, 1-Hb), 6.07 (pseudo t, J = 1.8 Hz, 2 H, 6-H and 7-H) 290 
ppm. 13C NMR: δ = 28.5 (CH2, C-9), 38.5 (CH, C-11), 46.3 (CH, C-4a), 47.9 (CH, C-5), 49.0 (CH, C-291 
5a), 49.4 (CH, C-8), 52.0 (CH3, C-3-COOCH3), 52.3 (CH3, C-4-COOCH3), 52.4 (CH, C-8a), 53.3 (C, 292 
C-9a), 56.6 (CH, C-4), 59.5 (CH, C-10), 71.9 (CH2, C-1), 88.0 (C, C-3), 136.3 (CH, C-7), 136.8 (CH, 293 
C-6), 170.4 (C, C-3- COOCH3), 171.5 (C, C-4-COOCH3) ppm. 294 
 295 
Dimethyl (1R,4S)-7,7-Bis(iodomethyl)bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (15) (a) 296 
Mixture of Alcohol 8, its C-7 Epimer, and Dimethyl (1R,4S)-7,7-297 
Bis(hydroxymethyl)bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (13): pTsOH·H2O (144 mg, 298 
0.76 mmol) was added to a solution of diacetate 7 (1.34 g, 3.80 mmol) in anhydrous MeOH (13.5 mL), 299 
and the resulting solution was heated under reflux for 6.5 h. The solution was cooled to room 300 
temperature, and the solvent was removed under vacuum. The residue was dissolved in CH2Cl2 (30 301 
mL). This solution was washed with saturated aqueous NaHCO3 solution  (2  8 mL) and brine (10 mL), 302 
dried (anhydrous Na2SO4), and concentrated in vacuo to give a mixture of diol 13 and tricyclic 303 
alcohols8 and 9, approximate ratio 13/8/9 20:12:5 by 1H NMR spectroscopy (by integration of the 304 
olefinic signals) (837 mg) as a yellow oil, which was used as such in the next step. The combined 305 
aqueous  washings were extracted with CH2Cl2 (3  20 mL). These combined organic extracts were 306 
washed with brine (10 mL), dried (anhydrous Na2SO4), and concentrated in vacuo to give an orange 307 
oily residue (120 mg). This was a mixture of diol 13 and a stereoiso meric mixture of tricyclic alcohols 8 308 
and 9, approximate ratio 13/8/9 10:1.3:1 by 1H NMR spectroscopy. 309 
 310 
(b) Mixture of Mesylate 10, its C-7 Epimer, and Dimethyl (1R,4S)-7,7-311 
Bis(methylsulfonyloxymethyl)bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (14): 312 
Methanesulfonyl chloride (0.6 mL, 7.5 mmol) was added dropwise to a cold (0 °C, ice/water bath) and 313 
magnetically stirred solution of a mixture of diol 13 and alcohols 8 and 9 (837 mg, approximate ratio 314 
13/8/9 20:12:5, 1.69 mmol 13, 1.43 mmol 8 + 9) and anhydrous Et3N (1.7 mL, 12.5 mmol) in anhydrous 315 
CH2Cl2 (34 mL) under an Ar atmosphere. The mixture was stirred at this temperature for 1.5 h. 316 
Saturated aqueous NaHCO3 (2.5 mL) was added, and the organic phase was separated, and washed with 317 
saturated aqueous Na  HCO3 (3  10 mL). The combined aqueous phases were extracted with CH2Cl2 318 
 (3  20 mL). The combined organic phase and extracts were washed with water (15 mL) and brine (15 319 
mL), dried (anhydrous Na2SO4), and concentrated in vacuo to give a mixture of dimesylate 14 and the 320 
tricyclic mesylates 10 and its C-7 epimer (1.15 g) as an orange oil. 321 
 322 
(c) Dimethyl (1R,4S)-7,7-Bis(iodomethyl)bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (15): 323 
Powdered NaI (4.86 g, 32.4 mmol) was added to a solution of dimesylate 14 and monomesylates 10 and 324 
its C-7 epimer (1.15 g, 1.60 mmol 14 and 1.36 mmol 10 + C-7 epimer) in anhydrous acetone (36 mL). 325 
The mixture was heated under reflux for 16 h. The mixture was then cooled to room temperature, and 326 
the solvent was removed under reduced pressure. The resulting yellow solid residue (6.1 g) was 327 
subjected to column chromatography [silica gel 35–70 μm (20 g), hexane/EtOAc mixtures] to give, on 328 
elution with hexane/EtOAc, 97.5:2.5, diiodide 15 (574 mg, 31% from diacetate 7) as a yellow oil, and 329 
on elution with hexane/ EtOAc, 85:15, a stereoisomeric mixture of iodides 11 and its C-7 epimer (404 330 
mg, 28% from diacetate 7) as a pale yellow oil. 331 
Analytical and spectroscopic data for 15: Rf (silica gel, 10 cm, hexane/ EtOAc, 3:7): 0.62. IR (ATR): ν˜ 332 
= 2998 (m), 2950 (m), 2849 (w), 1731 (s), 1713 (s), 1629 (m), 1434 (s), 1324 (s), 1281 (s), 1255 (s), 333 
1222 (s), 1202 (s), 1165 (m), 1100 (s), 1053 (m), 821 (m), 778 (m), 762 (m), 732 (m), 643 (m) cm–1. 334 
HRMS: calcd. for [C13H14I2O4 + H]+ 488.9054; found 488.9051; calcd. for [C13H14I2O4 + 335 
Na]+510.8874; found 510.8864. 1H NMR: δ = 3.716 (br. s, 2 H, syn-CH2I), 3.720 (br. s, 2 H, anti-336 
CH2I), 3.81 [s, 6 H, C-2(3)-COOCH3], 3.84 [t, J = 2.0 Hz, 2 H, 1(4)-H], 6.92 [pseudo t, J = 2.0 Hz, 2 337 
H,5(6)-H] ppm. NOESY: irradiation at δ = 6.92 [5(6)-H] ppm shows an NOE with the protons at δ = 338 
3.84 [1(4)-H] and 3.716 (syn-CH2I) ppm. 13C NMR: δ = 11.5 (CH2I), 12.3 (CH2I), 52.3 (CH3, 2 339 
COOCH3), 60.7 [CH, C-1(4)], 87.2 (C, C-7), 141.1 [CH, C-5(6)], 150.0 [C, C-2(3)], 164.6 [C, C-2(3)-340 




dicarboxylate(16): In a 10 mL flask, KH (30% in mineral oil; 134 mg, 1.0 mmol) was washed with 345 
 anhydrous THF (5  2 mL) under an Ar atmosphere. Anhydrous THF (2 mL) was added to the washed 346 
KH, and the suspension was cooled to 0 °C in an ice/water bath. Freshly distilled cyclopentadiene (0.1 347 
mL, 73 mg, 1.1 mmol) was added, and the mixture was stirred at this temperature for 10 min. 18-Crown-348 
6 (13 mg, 50 μmol, 5 mol-% relative to KH) was added, and the mixture was stirred at 0 °C for 10 min, 349 
and then at room temperature for 15 min. A solution of diiodide 15 (83 mg, 0.17 mmol) in anhydrous 350 
DMF (1 mL) was prepared in a 10 mL flask equipped with a magnetic stirrer bar and a reflux condenser, 351 
under an Ar atmosphere. The solution was cooled to 0 °C in an ice/water bath, and then part of the 352 
above solution of potassium cyclopentadienide (0.5 m; 0.75 mL, 0.37 mmol) was added dropwise. The 353 
mixture was stirred at 0 °C for 5 min, and at room temperature for 10 min, and then it was heated to 90 354 
°C for 17 h. The mixture was cooled to room temperature, then MeOH (20 μL) was added, and the 355 
mixture was stirred for 10 min. Then, EtOAc (5 mL) and water (5 mL) were added and the organic 356 
phase was separated.  The aqueous phase was extracted with EtOAc (4  15 mL). The combined organic 357 
phases were washed with saturated aqueous    NaHCO3 (3  5 mL), water (2  8 mL) and brine (8 mL), 358 
dried (anhydrous Na2SO4), and concentrated in vacuo to give crude diester 16 (73 mg) as a brown 359 
paste. This material was subjected to column chromatography [35–70 μm silica gel (1.5 g), 360 
hexane/EtOAc mixtures] to give, on elution with hexane/EtOAc, 99:1 to 95:5, diester 16 (30 mg, 49%) 361 
as a pale yellow oil. By treating this oil with Et2O, and washing the solid thus formed with pentane, an 362 
analytical sample of 16 was obtained as a pale grey solid. m.p. 92.5–94 °C. Rf (silica gel, 10 cm, 363 
hexane/EtOAc, 3:7): 0.50. IR (ATR): ν˜ = 3055 (w), 2944 (m), 2912 (m), 2842 (m), 1745 (s), 1727 (s), 364 
1432 (m), 1315 (m), 1256 (s), 1241 (s), 1224 (s), 1152 (s), 1141 (s), 1106 (s), 1070 (s), 1038 (s), 1028 365 
(s), 1010 (s), 741 (m), 709 (s), 665 (m) cm–1. C23H24O4·1/3H2O (370.45): C 74.57, H 6.71%; found C 366 
74.63, H 7.00%. HRMS: calcd. for [C23H24O4 + H]+ 365.1747; found 365.1754. 1H NMR: δ = 1.49 367 
(d, J = 2.8 Hz, 2 H, 12-H2), 1.54 (d, J = 2.8 Hz, 2 H, 10-H2), 1.78–1.82 (m, 1 H, 11-H), 1.83 [s, 2 H, 368 
4a(9)-H], 1.92–1.95 (m, 1 H, 10a-H), 1.98 [s, 2 H, 4b(8a)-H], 2.38–2.40 [m, 2 H, 5(8)-H], 2.69–2.71 [m, 369 
2 H, 1(3a)-H], 3.59 [s, 6 H, C- 4(13)-COOCH3], 6.03 [t, J = 1.8 Hz, 2 H, 6(7)-H], 6.15 [t, J = 1.8 Hz, 2 370 
H, 2(3)-H] ppm. 13C NMR: δ = 34.3 (CH2, C-10), 35.2 (CH2, C-12), 42.27 [CH2, C-4a(9)], 42.34 (C, 371 
C-9a), 49.3 [CH, C- 5(8)], 51.2 [CH3, C-4(13)-COOCH3], 51.9 (CH, C-11), 53.5 (CH, C-10a), 54.7 372 
[CH, C-4a(9)], 54.8 [CH, C-1(3a)], 64.6 [C, C-4(13)], 137.2 [CH, C-6(7)], 137.4 [CH, C-2(3)], 172.4 373 
[C, C-4(13)-COOCH3] ppm. 374 
 375 
X-ray Crystal-Structure Determination of Compound 8: A colorless prism-like specimen of 376 
C13H16O6, approximate dimensions    0.228 mm 0.427 mm 0.578 mm, was used for the X-ray 377 
crystallographic analysis. The X-ray intensity data were measured with a D8 Venture system equipped 378 
with a Multilayer monochromator and a Mo microfocus (λ = 1.54178 Å). A total of 4683 frames were 379 
collected. The total exposure time was 26.02 h. The frames were integrated with the Bruker SAINT 380 
software package using a narrow- frame algorithm. The integration of the data using a monoclinic unit 381 
cell yielded a total of 13259 reflections to a maximum θ angle of 72.20° (0.81 Å resolution), of which 382 
4742 were independent (average redundancy 2.796, completeness: 98.7%, Rint = 3.42%, Rsig = 3.56 383 
%), and 4718 (99.49%) were greater than 2σ(F2). The final cell constants of a = 5.8773(8) Å, b = 384 
30.253(4) Å, c = 7.0235(9) Å, β = 100.153(3)°, V = 1229.3(3) Å3, are based on the refinement of the 385 
XYZ-centroids of 120 reflections above 20σ(I)    with 21.75°  2θ  116.5°. Data were corrected for 386 
absorption effects using the multi-scan method (SADABS). The calculated minimum and maximum 387 
transmission coefficients (based on crystal size) are 0.6325 and 0.7536. The structure was solved using 388 
the Bruker SHELXTL software package, and refined using SHELXL[18] and the space group P21, with 389 
Z = 4 for the formula unit, C13H16O6. The final anisotropic full-matrix least-squares refinement on F2 390 
with 353 variables converged at R1 = 3.18%, for the observed data and wR2 = 8.72% for all data. The 391 
goodnessof- fit was 1.051. The largest peak in the final difference electron density synthesis was 0.278 392 
eÅ–3 and the largest hole was –0.218 eÅ–3 with an RMS deviation of 0.044 eÅ–3. On the basis of the 393 
final model, the calculated density was 1.449 gcm–3 and F(000), 568 e (Table 1). 394 
 395 
X-ray Crystal-Structure Determination of Compound 12: A colorless prism-like specimen of 396 
C18H20O5, approximate dimensions    0.222 mm 0.308 mm 0.554 mm, was used for the X-ray 397 
crystallographic analysis. The X-ray intensity data were measured with a D8 Venture system equipped 398 
with a multilayer monochromator and a Mo microfocus (λ = 0.71073 Å). The frames were integrated 399 
with the Bruker SAINT software package using a Narror-frame algorithm. The integration of the data 400 
using a triclinic unit cell yielded a total of 15320 reflections to a maximum θ angle of 26.45° (0.80 Å 401 
resolution), of which 3007 were independent (average redundancy 5.095, completeness: 99.6%, Rint = 402 
2.06%, Rsig = 1.39 %), and 2847 (94.68%) were greater than 2σ(F2). The final cell constants of a = 403 
9.1711(3) Å, b = 9.8643(4) Å, c = 10.2303(4) Å, α = 66.5310(10)°, β = 64.5980(10)°, γ = 65.2720(10)°, 404 
V = 731.86(5) Å3, are based on the refinement of the XYZ-centroids of reflections above 20σ(I). Data 405 
were corrected for absorption effects using the multi-scan method (SADABS). The calculated minimum 406 
and maximum transmission coefficients (based on crystal size) are 0.6847 and 0.7454. The structure was 407 
solved using the Bruker SHELXTL software package, and refined using SHELXL[18] and the space 408 
group P1¯ , with Z = 2 for the formula unit, C18H20O5. The final anisotropic full-matrix least-squares 409 
refinement on F2 with 210 variables converged at R1 = 3.85%, for the observed data and wR2 = 10.47% 410 
for all data. The goodness-of-fit was 1.081. The largest peak in the final difference electron density 411 
synthesis was 0.323 eÅ–3 and the largest hole was –0.292 eÅ–3 with an RMS deviation of 0.064 eÅ–3. 412 
On the basis of the final model, the calculated density was 1.435 g cm–3 and F(000), 336 e (Table 1). 413 
 414 
X-ray Crystal-Structure Determination of Compound 16: A colorless plate-like specimen of 415 
C23H24O4, approximate dimensions    0.096 mm 0.216 mm 0.285 mm, was used for the X-ray 416 
crystallographic analysis. The X-ray intensity data were measured with a D8 Venture system equipped 417 
with a multilayer monochromator and a Mo microfocus (λ = 0.71073 Å). The frames were integrated 418 
with the Bruker SAINT software package using a narrow-frame algorithm. The integration of the data 419 
using a monoclinic unit cell yielded a total of 46427 reflections to a maximum θ angle of 28.34° (0.75 Å 420 
resolution), of which 4298 were independent (average redundancy 10.802, completeness: 99.8%, Rint = 421 
4.10%, Rsig = 1.82 %), and 3654 (85.02%) were greater than 2σ(F2). The final cell constants of a = 422 
9.6672(4) Å, b = 10.5955(5) Å, c = 17.0896(7) Å, β = 99.698(2)°, V = 1725.45(13) Å3, are based on the 423 
refinement of the XYZ-centroids of reflections above 20σ(I). Data were corrected for absorption effects 424 
using the multiscan method (SADABS). The calculated minimum and maximum transmission 425 
coefficients (based on crystal size) are 0.7050 and 0.7457. The structure was solved using the Bruker 426 
SHELXTL Software Package, and refined using SHELXL[18] and the space group P21/c, with Z = 4 for 427 
the formula unit, C23H24O4. The final anisotropic full-matrix leastsquares refinement on F2 with 258 428 
variables converged at R1 = 3.95%, for the observed data and wR2 = 10.72% for all data. The goodness-429 
of-fit was 1.047. The largest peak in the final difference electron density synthesis was 0.364 eÅ–3 and 430 
the largest hole was –0.265 eÅ–3 with an RMS deviation of 0.058 eÅ–3. On the basis of the final model, 431 
the calculated density was 1.403 gcm–3 and F(000), 776 e (Table 1). 432 
CCDC-1063995 (for 8), -1063996 (for 12), and 1063997 (for 16) contain the supplementary 433 
crystallographic data for this paper. These data can be obtained free of charge from The Cambridge 434 
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Legends to figures 478 
 479 
Figure 1. A polynorbornane-based ligand. 480 
 481 
Scheme 1. Preparation of cyclopentadiene 6; DMAP = 4-(dimethylamino) pyridine. 482 
 483 
Scheme 2. Synthesis of hexacyclo derivative 12. 484 
 485 
Figure 2. ORTEP representation of one of the enantiomers of alcohol 8. 486 
 487 
Figure 3. ORTEP representation of one of the enantiomers of polycycle 488 
12. 489 
 490 
Scheme 3. Synthesis of polycyclo derivative 16. 491 
 492 
Figure 4. ORTEP representation of octacyclo 16. 493 
 494 
495 


































Table 1. Experimental data[a] of the X-ray crystal-structure determination of compounds 8, 12 and 16. 530 
 531 
 532 
 533 
